LeMaitre Vascular
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 24 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.9 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 103.32% +0.90pp
- Institutions
- 371 -24
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| George LeMaitre | Chairperson & CEO | 6.40% |
| John O'Connor | Independent Director | 0.27% |
| Joseph Pellegrino | Director | 0.07% |
| David Roberts | President | 0.03% |
| John Roush | Independent Director | 0.03% |
| Trent Kamke | Officer | 0.02% |
| Lawrence Jasinski | Independent Director | 0.02% |
| Bridget Ross | Former Independent Director | 0.01% |
| Martha Shadan | Independent Director | 0.01% |
| Dorian LeBlanc | Chief Financial Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | George LeMaitre | Chairperson & CEO | Other Derivative Acquisition | +71 | -- |
| 2026-09-02 | David Roberts | President | Other Derivative Acquisition | +24 | -- |
| 2026-09-02 | Lawrence Jasinski | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | John Roush | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | John O'Connor | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | Trent Kamke | Officer | Other Derivative Acquisition | +13 | -- |
| 2026-09-02 | Joseph Pellegrino | Director | Other Derivative Acquisition | +22 | -- |
| 2026-09-02 | Martha Shadan | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | Dorian LeBlanc | Chief Financial Officer | Other Derivative Acquisition | +6 | -- |
| 2026-08-31 | John Roush | Independent Director | Derivative Exercise and Retained | +3,444 | $48.60 |
| 2026-07-28 | Bridget Ross | Former Independent Director | Intent to Sell (Form 144) | -4,322 | $103.94 |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Acquisition | +11,974 | -- |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Disposition | -11,974 | -- |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Derivative Acquisition | +61 | -- |
| 2026-06-03 | David Roberts | President | Other Derivative Acquisition | +21 | -- |
| 2026-06-03 | Lawrence Jasinski | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | John Roush | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | John O'Connor | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | Trent Kamke | Officer | Other Derivative Acquisition | +11 | -- |
| 2026-06-03 | Joseph Pellegrino | Director | Other Derivative Acquisition | +19 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
LeMaitre Vascular discussion 0 comments